Target intelligence / Profile preview

Pro-apoptotic signaling proteins

Molecular classification
Bcl-2 family protein, Caspase, Intracellular signaling protein, BH3-only protein
01

Overview

Pro-apoptotic signaling proteins are a functional class of intracellular molecules that initiate and execute programmed cell death (apoptosis). This group primarily comprises members of the Bcl-2 family, including effectors like BAX and BAK, and BH3-only proteins such as BIM, PUMA, and NOXA, as well as the caspase family of proteases [1][3]. These proteins are critical for maintaining cellular homeostasis by eliminating damaged or redundant cells; however, their dysregulation is a hallmark of various diseases. In many cancers, pro-apoptotic proteins are suppressed or sequestered by overexpressed anti-apoptotic proteins (e.g., BCL-2, BCL-XL), allowing malignant cells to survive despite oncogenic stress [2]. Therapeutic strategies, most notably BH3 mimetics like Venetoclax, work by binding to anti-apoptotic proteins, thereby releasing pro-apoptotic factors to trigger mitochondrial outer membrane permeabilization (MOMP) and subsequent cell death [4]. While highly effective in certain hematologic malignancies, targeting these pathways requires careful management of safety concerns such as tumor lysis syndrome and myelosuppression [3].

Other names
Pro-apoptotic factorsPro-apoptotic Bcl-2 family membersDeath-promoting proteinsApoptotic effectors
02

Mechanism of action

Induction of mitochondrial outer membrane permeabilization (MOMP) through the displacement of pro-apoptotic BH3-only proteins from anti-apoptotic proteins or direct activation of BAX/BAK, leading to the activation of the caspase cascade [1][3][4].

03

Biological functions

ApoptosisProgrammed cell deathSignal transductionMitochondrial outer membrane permeabilization
04

Disease associations

CancerNeurodegenerative diseaseAutoimmune diseaseInflammation
05

Safety considerations

Tumor lysis syndromeNeutropeniaThrombocytopeniaGastrointestinal toxicity
06

Interacting drugs

Venetoclax

5 more in the full profile.

07

Biomarkers

BCL2 expressionBAX/BCL2 ratioBH3 profilingCleaved caspase-3

Beyond the preview

Go deeper on Pro-apoptotic signaling proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-apoptotic signaling proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call